Cargando…

Immunogenicity of a Killed Bivalent (O1 and O139) Whole Cell Oral Cholera Vaccine, Shanchol, in Haiti

BACKGROUND: Studies of the immunogenicity of the killed bivalent whole cell oral cholera vaccine, Shanchol, have been performed in historically cholera-endemic areas of Asia. There is a need to assess the immunogenicity of the vaccine in Haiti and other populations without historical exposure to Vib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charles, Richelle C., Hilaire, Isabelle J., Mayo-Smith, Leslie M., Teng, Jessica E., Jerome, J. Gregory, Franke, Molly F., Saha, Amit, Yu, Yanan, Kováč, Paul, Calderwood, Stephen B., Ryan, Edward T., LaRocque, Regina C., Almazor, Charles P., Qadri, Firdausi, Ivers, Louise C., Harris, Jason B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006712/ https://www.ncbi.nlm.nih.gov/pubmed/24786645 http://dx.doi.org/10.1371/journal.pntd.0002828

Ejemplares similares

Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh
por: Kaisar, M. Hasanul, et al.
Publicado: (2023)

Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139
por: Kamruzzaman, Mohammad, et al.
Publicado: (2021)

Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults
por: Falkard, Brie, et al.
Publicado: (2019)

Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults
por: Matias, Wilfredo R., et al.
Publicado: (2016)

High depth, whole-genome sequencing of cholera isolates from Haiti and the Dominican Republic
por: Sealfon, Rachel, et al.
Publicado: (2012)

Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014
por: Chowdhury, Fahima, et al.
Publicado: (2015)

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines
por: Capeding, Maria Rosario Z., et al.
Publicado: (2017)

Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide
por: Alam, Mohammad Murshid, et al.
Publicado: (2014)

Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017
por: Matias, Wilfredo R., et al.
Publicado: (2023)

Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study
por: Franke, Molly F, et al.
Publicado: (2018)

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers
por: Islam, Kamrul, et al.
Publicado: (2018)

Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh
por: Aktar, Amena, et al.
Publicado: (2018)

Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh
por: Aktar, Amena, et al.
Publicado: (2021)

A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice
por: Sayeed, Md. Abu, et al.
Publicado: (2015)

Reemergence of Cholera in Haiti
por: Rubin, Daniel H. F., et al.
Publicado: (2022)

Vibrio cholerae genomic diversity within and between patients
por: Levade, Inès, et al.
Publicado: (2017)

Systemic, Mucosal, and Memory Immune Responses following Cholera
por: Ryan, Edward T., et al.
Publicado: (2021)

Individuals with Le(a+b−) Blood Group Have Increased Susceptibility to Symptomatic Vibrio cholerae O1 Infection
por: Arifuzzaman, Mohammad, et al.
Publicado: (2011)

Use of Oral Cholera Vaccine in Haiti: A Rural Demonstration Project
por: Ivers, Louise C., et al.
Publicado: (2013)

622. Increased IgA Coating of Gut Microbes After Administration of Killed, Whole-Cell Oral Cholera Vaccine
por: Weil, Ana, et al.
Publicado: (2018)

Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India
por: Raghava Mohan, Venkata, et al.
Publicado: (2019)

Characterization of Two Cryptic Plasmids Isolated in Haiti from Clinical Vibrio cholerae Non-O1/Non-O139
por: Ceccarelli, Daniela, et al.
Publicado: (2017)

Cholera Vaccination Campaign Contributes to Improved Knowledge Regarding Cholera and Improved Practice Relevant to Waterborne Disease in Rural Haiti
por: Aibana, Omowunmi, et al.
Publicado: (2013)

High quality reference genomes for toxigenic and non-toxigenic Vibrio cholerae serogroup O139
por: Dorman, Matthew J., et al.
Publicado: (2019)

Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh
por: Akter, Aklima, et al.
Publicado: (2019)

Household and Individual Risk Factors for Cholera among Cholera Vaccine Recipients in Rural Haiti
por: Matias, Wilfredo R., et al.
Publicado: (2017)

Cellular and Cytokine Responses to Salmonella enterica Serotype Typhi Proteins in Patients with Typhoid Fever in Bangladesh
por: Bhuiyan, Saruar, et al.
Publicado: (2014)

Correction: Cholera Vaccination Campaign Contributes to Improved Knowledge Regarding Cholera and Improved Practice Relevant to Waterborne Disease in Rural Haiti
por: Aibana, Omowunmi, et al.
Publicado: (2013)

Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba
por: Hossain, Motaher, et al.
Publicado: (2019)

Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools
por: Sayeed, Md. Abu, et al.
Publicado: (2018)

Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility
por: Charles, Richelle C., et al.
Publicado: (2020)

Laboratory evaluation of immunochromatographic rapid diagnostic tests for cholera in Haiti
por: Matias, Wilfredo R., et al.
Publicado: (2017)

Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study
por: Ali, Mohammad, et al.
Publicado: (2017)

Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies
por: Kauffman, Robert C., et al.
Publicado: (2021)

Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae
por: Weil, Ana A., et al.
Publicado: (2019)

Susceptibility to Vibrio cholerae Infection in a Cohort of Household Contacts of Patients with Cholera in Bangladesh
por: Harris, Jason B., et al.
Publicado: (2008)

Transmission of Vibrio cholerae Is Antagonized by Lytic Phage and Entry into the Aquatic Environment
por: Nelson, Eric J., et al.
Publicado: (2008)

Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh
por: Falkard, Brie, et al.
Publicado: (2015)

Phase Variable O Antigen Biosynthetic Genes Control Expression of the Major Protective Antigen and Bacteriophage Receptor in Vibrio cholerae O1
por: Seed, Kimberley D., et al.
Publicado: (2012)

Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine
por: Akter, Aklima, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fkh0u5hjccpqvk4lu6uep39ck9